SSY GROUP LIMITED revenue for the last year amounted to 6.46 B HKD, the most of which — 6.30 B HKD — came from its highest performing source at the moment, Intravenous Infusion Solution and Others, the year earlier bringing 6.26 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SSY GROUP LIMITED 5.80 B HKD, and the year before that — 5.54 B HKD.